Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Retained Earnings (2023 - 2026)

Cannabis Bioscience International Holdings' Retained Earnings history spans 4 years, with the latest figure at -$6.2 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 9.09% to -$6.2 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$6.2 million, a 9.09% decrease, with the full-year FY2025 number at -$5.9 million, down 10.29% from a year prior.
  • Retained Earnings hit -$6.2 million in Q1 2026 for Cannabis Bioscience International Holdings, down from -$6.1 million in the prior quarter.
  • Over the last five years, Retained Earnings for CBIH hit a ceiling of -$4.7 million in Q2 2023 and a floor of -$6.2 million in Q1 2026.
  • Historically, Retained Earnings has averaged -$5.6 million across 4 years, with a median of -$5.5 million in 2024.
  • The widest YoY moves for Retained Earnings: up 5.61% in 2024, down 13.91% in 2024.
  • Tracing CBIH's Retained Earnings over 4 years: stood at -$5.2 million in 2023, then fell by 5.61% to -$5.5 million in 2024, then fell by 10.79% to -$6.1 million in 2025, then decreased by 1.71% to -$6.2 million in 2026.
  • Business Quant data shows Retained Earnings for CBIH at -$6.2 million in Q1 2026, -$6.1 million in Q4 2025, and -$6.0 million in Q3 2025.